Novel balloon angioplasty inflation device for safer, more effective artery widening
Official title: Novel Balloon Angioplasty Inflation Device
Funded at Minnesota Healthsolutions Corporation · NIH-11408243 · Data updated 2026-11-12
A new balloon angioplasty inflation device is being developed to make artery widening safer and more effective for people with atherosclerotic cardiovascular disease.
Quick facts
| Grant type | Sbir 1 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Minnesota Healthsolutions Corporation NIH-funded |
| Lab location | 1 site (Saint Paul, United States) |
| Project start | August 15, 2026 |
| Project end | August 14, 2027 |
| Funding year | 2026 |
| Award (this year) | $329,537 |
| NIH project number | 1R43HL187101-01 |
| Project ID | NIH-11408243 on NIH RePORTER |
Who could benefit from this research
✓Could help
Patients with atherosclerotic cardiovascular disease who may need balloon angioplasty could benefit from improved device safety and efficacy.
✕Less likely to help
This device may not benefit patients who do not require balloon angioplasty or who have conditions outside the scope of atherosclerotic disease.
What this research studies
This project aims to create a prototype inflation device tailored to how arteries respond in different parts of the body, with the goal of reducing stress on artery walls during the procedure. The team will design and build a prototype, then test its performance in simulations and early bench assessments. If successful, the device could help doctors achieve better luminal opening with fewer complications for patients facing coronary, peripheral, or stroke-related arterial blockages.
Why it matters
Potential benefit: If successful, patients could experience safer balloon angioplasty procedures with improved vessel opening and potentially fewer complications.
How similar studies have gone: Previous balloon inflation devices exist, but this project emphasizes arterial wall mechanics and bed-specific elasticity, representing a newer approach.
Where this research is happening
-
Minnesota Healthsolutions Corporation
Saint Paul, United States Active
Researchers
- Principal investigator: Rydberg, Nick — Minnesota Healthsolutions Corporation
- Study coordinator: Rydberg, Nick
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.